John Cheslock

John Cheslock has a strong background in market access, pricing, and contracting within the pharmaceutical industry. John currently serves as the Vice President of Market Access and Pricing at Dermavant Sciences. Prior to that, they held positions at Galderma Laboratories, L.P., Galderma, Orexo US, Inc, Archimedes Pharma, Novartis Pharmaceuticals, Schering-Plough, and Coventry Corporation. Throughout their career, they have successfully developed and implemented pricing and contracting strategies, negotiated contracts, and facilitated appropriate product reimbursement and access. Additionally, they have experience in account management, customer/brand strategy development, and contract performance monitoring. Overall, John Cheslock brings a wealth of knowledge and expertise in market access and pricing to their current role at Dermavant Sciences.

John Cheslock has an MBA from Penn State University and a BS in Health Planning Administration from The Pennsylvania State University.